Literature DB >> 21327510

Challenges and benefits of an inpatient anticoagulation service: one hospital's experience.

Allison Burnett1, Richard D'Angio, Laura E Earl, David Garcia.   

Abstract

While outpatient anticoagulation services (AMS) have existed extensively for a number of years, inpatient AMS have only recently begun to be implemented on a widespread basis. This is in direct response to anticoagulation regulations set forth by entities such as the Joint Commission (TJC) and the Centers for Medicare and Medicaid services (CMS). Hospitals not complying with these regulations are at risk for either financial or accreditation punition. Inpatient AMS have reported positive impacts on patient outcomes in the literature, which gives hospitals an additional impetus to provide this type of service. Inpatient AMS pose many challenges, including identification of resources for development and implementation of the service, means to make changes to the service as it evolves and effectively tracking performance of the service. Using a well-planned, methodical approach for implementation has helped our institution capitalize on the numerous potential benefits of an inpatient AMS, including improved inpatient anticoagulation therapy, improved transitions of care and enhanced interdisciplinary practices.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327510     DOI: 10.1007/s11239-011-0563-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

1.  Joint Commission's requirements for warfarin dosing guidelines.

Authors:  Darryl S Rich
Journal:  Am J Health Syst Pharm       Date:  2010-09-15       Impact factor: 2.637

2.  Dosing guidelines, not protocols, for managing warfarin therapy.

Authors:  Ann K Wittkowsky; Sarah A Spinler; William Dager; Michael P Gulseth; Edith A Nutescu
Journal:  Am J Health Syst Pharm       Date:  2010-09-15       Impact factor: 2.637

3.  Establishing an inpatient anticoagulation service: a step by step review.

Authors:  John Viercinski; Lynda Thomson; Joseph Wilson; Geno J Merli
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

4.  A baseline study of anticoagulant management in UK hospitals.

Authors:  Annette Lankshear; Jane Harden; Karin Lowson
Journal:  Qual Saf Health Care       Date:  2010-08-02

5.  Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.

Authors:  W E Dager; J M Branch; J H King; R H White; R S Quan; N A Musallam; T E Albertson
Journal:  Ann Pharmacother       Date:  2000-05       Impact factor: 3.154

Review 6.  Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2004-08       Impact factor: 4.705

7.  Survey of pharmacist-managed inpatient anticoagulation services.

Authors:  Katherine W Phillips; Ann K Wittkowsky
Journal:  Am J Health Syst Pharm       Date:  2007-11-01       Impact factor: 2.637

8.  Implementing anticoagulation management by pharmacists in the inpatient setting.

Authors:  William E Dager; Michael P Gulseth
Journal:  Am J Health Syst Pharm       Date:  2007-05-15       Impact factor: 2.637

9.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.

Authors:  David A Garcia; Daniel M Witt; Elaine Hylek; Ann K Wittkowsky; Edith A Nutescu; Alan Jacobson; Stephan Moll; Geno J Merli; Mark Crowther; Laura Earl; Richard C Becker; Lynn Oertel; Amir Jaffer; Jack E Ansell
Journal:  Ann Pharmacother       Date:  2008-06-17       Impact factor: 3.154

View more
  1 in total

Review 1.  Impact of target-specific oral anticoagulants on transitions of care and outpatient care models.

Authors:  Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.